ESI-MS/MS를 이용한 아실카르니틴과 아미노산의 정량분석

Quantitative Analysis of Acylcarnitines and Amino Acids Using ESI-MS/MS

  • Kim, Hohyun (Department of Special Biochemistry, Seoul Medical Science Institute (SCL)) ;
  • Han, Sang-Beom (Department of Special Biochemistry, Seoul Medical Science Institute (SCL)) ;
  • Yoon, Hye-Ran (Department of Special Biochemistry, Seoul Medical Science Institute (SCL))
  • 투고 : 2001.08.02
  • 발행 : 2001.10.25

초록

본 연구에서는 ESI-MS/MS를 이용해 혈액내에서 아실카르니틴과 아미노산을 신속하게 정량분석하는 방법을 개발하였다. 아실카르니틴과 아미노산은 3N butanolic hydrogen chloride를 사용하여 유도체화 과정을 거친 뒤 이중질량분석기로 분석하였다. 아실카르니틴은 precursor 85 ion scan을 사용하여 분석하였고, 아미노산들중 알라닌, 발린, 루신/이소루신, 메티오닌, 페닐알라닌, 타이로신, 아스파르트산, 글루탐산 등은 neutral loss 102 scan, 오르니틴과 시트롤린은 neutral loss 119 scan, 글리신은 neutral loss 56 scan, 아르기닌은 neutral loss 161 scan 그리고 아르기니노석시닉산은 product ion 459 scan을 사용하여 분석하였다. 이 방법은 일반적인 액체 크로마토그래피나 아미노산 분석기에 비해서 시료의 전처리가 비교적 간단하며, 높은 감도와 좋은 재현성을 보여주었다.

In this study, a new quantitative analytical method has been developed for the rapid determination of acylcarnitines and amino acids in human blood using electrospray ionization / tandem mass spectrometry (ESI-MS/MS). Acylarmitines and amino acids were analyzed by tandem mass spectrometry after conversion to their butylesters through treatment with 3N butanolic hydrogen chloride. Acylcrnitines were analyzed using precursor 85 ion scan and alanine, valine, leucine/isoleucine, methionine, phenylalanine, tyrosine, aspartic acid and glutamic acid were analyzed using neutral loss 102 scan, ornitine and citrulline were analyzed neutral loss 119 scan, glycine was analyzed using neutral loss 56 scan, arginine was analyzed using neutral loss 161 scan and argininosuccinic acid was analyzed product ion 459 scan. This method reduced sample preparation time compared to that with conventional amino acid analyzer and liquid chromatography, with high sensitivity and good reproducibility.

키워드

참고문헌

  1. Clin. Chem. v.43 M.S. Rashed;M.P. Bucknall;D. Little;A. Awad;M. Jacob;M. Alamoudi;M. Alwattar;P.T. Ozand
  2. Organic acid in Man R.A. Chalmers;A.M. Lawson
  3. New Engl. J. Med. v.319 P. Rinaldo;J.T. O'Shea;R.D. Welch;K. Tanaka
  4. Pediatr. Res. v.19 C.P. Roe;D.S. Millington;D.A. Maltby;P. Kinnebrew
  5. In Clinical Aspects of Human Carnitine Deficiency C.R. Roe;D.S. Millington;D.A. Maltby;P. R. Borum(ed.)
  6. Anal. Chem. v.54 M. Barber;R.D. Bordoli;G.J. Elliot;D.R. Sedgwick;A.N. Tyler
  7. Anal. Biochem. v.180 D.S. Millington;D.L. Norwood;N. Kodo;C.R. Roe;F. Inoue
  8. J. Clin. Invest. v.79 A. Moon;W.J. Rhead
  9. J. Inher. Metab. Dis. v.13 D.S Millington;N. Kodo;D.L. Norwood;C.R. Roe
  10. Clin. Chem. v.42 D.H. Chace;S.L. Hillman;D.S. Millington;S. G. Kahler;B.W. Adam;H.L. Levy
  11. Int. J. Mass Spectrom Ion Processes v.111 D.S. Millington;N. Kodo;N. Terada;D. Roe;C.H. Chace